n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine has been researched along with Muscular Dystrophy, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heffner, RR; Hudecki, MS; Pollina, CM | 1 |
| Isogai, K; Katunuma, N; Noda, T; Ohzeki, M; Tarumoto, Y | 1 |
2 other study(ies) available for n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and Muscular Dystrophy, Animal
| Article | Year |
|---|---|
Limited benefit to genetically dystrophic chickens from a synthetic proteinase inhibitor: Ep475.
Topics: Animals; Calcium; Chickens; Creatine Kinase; Leucine; Motor Activity; Muscle Proteins; Muscles; Muscular Dystrophy, Animal; Pectoralis Muscles; Protease Inhibitors | 1983 |
Effects of cathepsin B, H, and D in pectoral muscle of dystrophic chickens (line 413) of in vivo administration of E-64-c (N-[N-(L-3-transcarboxyoxirane-2-carbonyl)-L-leucyl]-3-methyl-butylamine).
Topics: Animals; Cathepsin B; Cathepsin D; Cathepsin H; Cathepsins; Chickens; Cysteine Endopeptidases; Leucine; Muscles; Muscular Dystrophy, Animal; Protease Inhibitors | 1981 |